RxDoctor Payments Data

Harneet Singh, MD

Sleep Medicine · Tomball, TXNPI 1972963866

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 42.8% of the total.

$4,080in general payments, 2019–2025

Across 123 payments — averaging $33.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • AstraZeneca$429
  • Sanofi$307
  • Jazz Pharmaceuticals Inc.$256
  • GSK$195
  • Intuitive Surgical$125
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,02599%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,080 in reported general payments places this provider in the 70th percentile of 112 sleep medicine providers in Texas.

See all sleep medicine providers in Texas

Medicare billing

Part B allowed, 2024
$31,935
Medicare patients
86
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin39$205
Zolpidem Tartrate15$12

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Tomball

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →